The Analysis and AI Prospect Based on the Clinical Screening Results of Chronic Diseases

The incidence of chronic diseases is increasing year after year in China, which has caused a heavy burden of diseases. Clinical screening helps identify patients with chronic diseases, thereby reducing the mortality rate of chronic diseases through early diagnosis and treatment. Clinical trials have shown that AI (Artificial Intelligence) improves the accuracy of chronic diseases detection. In our study, high-risk factor questionnaire investigation were conducted among aged 40–69 residents of 25 community health service centres in a district, Detected high-risk people will be received the clinical screening. Then, the researchers analyse and evaluate the high-risk rate of the chronic diseases and the positive detection rate of clinical screening. A total of 4036 residents completed the assessment of high-risk groups in 2019. The high-risk rates of lung cancer, breast cancer, upper gastrointestinal cancer, colorectal cancer, liver cancer, cardiovascular-cerebrovascular diseases and cataracts were 57.85%, 22.13%, 74.63%, 41.65%, 53.39%, 83.94% and 20.24%, respectively. AI-aided chronic diseases screening increases the utilization rate of screening resources and increases the detection rate of chronic diseases, it is the direction of future efforts that exploring a new model of chronic disease screening based on AI plus medical.